Health Trials

Procalcitonin

2

Review clinical trials related to Procalcitonin. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.

Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Barzilai Medical CenterUpdated: Aug 18, 2026
Eligibility criteria

All patients hospitalized in internal medicine and geriatric wards with a diagno...

Age under 18 [+7]

Read more
Status: Recruiting

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.

Participants needed: 290
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Ain Shams UniversityUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

Age from 18 to 70 years old. [+2]

Pregnancy [+7]

Read more